Related Experiment Video
Updated: Aug 12, 2026
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
Published on: February 22, 2019
Abstract:
A two-compartment pharmcokinetic model was used to caracterize serum concentrations and to predict tissue accumulation of gentamicin in 47 treated patients. Postmortem tissues were obtained in six cases; in each instance, tissues yielded the predicted amount of drug. Slow release of tissue-bound gentamicin accounts for its prolonged retention in the body. The two-compartment model adequately predicts gentamicin accumulation from serum concentrations and explains why this antibiotic persists in serum and urine.
Insights
Gentamicin
Area of Science:
- Pharmacokinetics
- Drug Metabolism
- Antibiotic Therapy
Background:
- Gentamicin is a widely used antibiotic.
- Understanding its tissue distribution is crucial for effective treatment and minimizing toxicity.
- Previous models may not fully capture its complex pharmacokinetic profile.
Purpose of the Study:
- To characterize serum concentrations of gentamicin.
- To predict gentamicin tissue accumulation in patients.
- To elucidate the prolonged retention of gentamicin in the body.
Main Methods:
- Utilized a two-compartment pharmacokinetic model.
- Analyzed serum concentrations in 47 treated patients.
- Examined postmortem tissue samples from six cases for drug levels.
Main Results:
- The two-compartment model accurately predicted gentamicin tissue accumulation.
- Postmortem tissue analysis confirmed predicted drug levels.
- Slow release from tissue-bound gentamicin explains prolonged body retention.
Conclusions:
- The two-compartment model effectively predicts gentamicin accumulation from serum data.
- This model explains the persistence of gentamicin in serum and urine.
- Findings support optimized gentamicin dosing strategies.
